BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,099 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,776,000 | -4.4% | 45,153 | 0.0% | 0.38% | -13.8% |
Q3 2019 | $3,950,000 | +6.8% | 45,153 | 0.0% | 0.44% | +19.5% |
Q2 2019 | $3,698,000 | +0.7% | 45,153 | 0.0% | 0.36% | -11.4% |
Q1 2019 | $3,671,000 | +23.5% | 45,153 | 0.0% | 0.41% | +533.8% |
Q4 2018 | $2,972,000 | -14.6% | 45,153 | 0.0% | 0.06% | +8.3% |
Q3 2018 | $3,481,000 | +4.4% | 45,153 | 0.0% | 0.06% | +5.3% |
Q2 2018 | $3,334,000 | -14.2% | 45,153 | -24.5% | 0.06% | -19.7% |
Q1 2018 | $3,888,000 | +0.6% | 59,783 | 0.0% | 0.07% | +9.2% |
Q4 2017 | $3,864,000 | +3.0% | 59,783 | 0.0% | 0.06% | +1.6% |
Q3 2017 | $3,751,000 | +3.6% | 59,783 | 0.0% | 0.06% | +1.6% |
Q2 2017 | $3,619,000 | +16.6% | 59,783 | -0.2% | 0.06% | +14.5% |
Q1 2017 | $3,105,000 | +19.7% | 59,879 | +2.4% | 0.06% | +22.2% |
Q4 2016 | $2,593,000 | -6.9% | 58,479 | 0.0% | 0.04% | +9.8% |
Q3 2016 | $2,784,000 | +5.3% | 58,479 | 0.0% | 0.04% | -14.6% |
Q2 2016 | $2,644,000 | +3.8% | 58,479 | -5.7% | 0.05% | +4.3% |
Q1 2016 | $2,548,000 | -24.3% | 62,024 | -29.7% | 0.05% | -22.0% |
Q4 2015 | $3,366,000 | +16.1% | 88,224 | 0.0% | 0.06% | +20.4% |
Q3 2015 | $2,898,000 | -53.0% | 88,224 | 0.0% | 0.05% | -46.2% |
Q2 2015 | $6,170,000 | -5.5% | 88,224 | -7.4% | 0.09% | -7.1% |
Q1 2015 | $6,528,000 | -1.8% | 95,302 | +5.0% | 0.10% | -2.0% |
Q4 2014 | $6,649,000 | +2.1% | 90,722 | 0.0% | 0.10% | +1.0% |
Q3 2014 | $6,511,000 | -0.7% | 90,722 | 0.0% | 0.10% | -2.0% |
Q2 2014 | $6,559,000 | -1.7% | 90,722 | 0.0% | 0.10% | -9.8% |
Q1 2014 | $6,675,000 | +5.3% | 90,722 | -0.5% | 0.11% | +9.8% |
Q4 2013 | $6,339,000 | +5.9% | 91,142 | 0.0% | 0.10% | 0.0% |
Q3 2013 | $5,987,000 | -5.2% | 91,142 | 0.0% | 0.10% | -10.5% |
Q2 2013 | $6,313,000 | – | 91,142 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |